Press release
The world’s first potential therapy for an increasingly common respiratory illness has been identified following a trial led by an expert from the University of Dundee and a global biopharmaceutical company.
Press release
The world’s first potential therapy for an increasingly common respiratory illness has been identified following a trial led by an expert from the University of Dundee and a global biopharmaceutical company.
Press release
Artificial Intelligence has the capability to detect people living with the risk of experiencing heart failure, new University of Dundee research has discovered.
Press release
Experts at the University of Dundee have proven that the beta-blocker, Bisoprolol, can now be safely prescribed to patients with Chronic Obstructive Pulmonary Disease (COPD) for cardiac disease treatment.
Press release
A new study from the University of Dundee has found that hypertension patients who took blood pressure medication at a time aligned with their body clock had a reduced risk of heart attack.
Press release
Elevated levels of air pollution cause more children to be admitted to hospital with respiratory problems, a new study has found.
Press release
Cancer Research UK-funded scientists in Dundee have discovered how some cancer drugs can target the disease while sparing healthy tissue.
Press release
Dundee researchers have received a grant from JDRF, the leading global type 1 diabetes (T1D) research and advocacy organisation, to support a clinical trial that could potentially advance new life-saving treatment for people with T1D and heart failure.
Press release
The potential health effects of passive vaping are to be explored for the first time as part of an important new Scottish research study.
Press release
Scottish patients diagnosed with one of the least survivable cancers were 13% less likely to receive potentially curative treatment in the post-lockdown period, according to new University of Dundee research.
Press release
University of Dundee research has helped explain why a commonly used antibiotic can lead to an increased risk of heart attacks, opening up the possibility of precision prescribing based on a patient’s genes.
Press release
A treatment for gout presents no increased risk of cardiovascular events for patients compared to an older alternative, a major new study has found.
Press release
More than 2000 Tayside healthcare staff took part in a ground-breaking study looking at the prevalence of Covid-19 antibodies in healthcare workers in Scotland.
Press release
The University of Dundee is to bring its expertise in diabetes, precision medicine and machine learning to bear on a project aiming to improve the outcomes for people with diabetes in Malaysia.
Press release
Researchers and clinicians from the University of Dundee and NHS Tayside hope to develop technology capable of diagnosing skin cancer after benefitting from a major UK Government investment in artificial intelligence.
Press release
Scientists from the University of Dundee have announced key findings from two separate studies they believe could unlock the development of a new type of treatment for lung conditions, including Covid-19.
Press release
Researchers at the University of Dundee have enhanced the understanding of how a new class of anti-diabetes drugs appears to improve the outcome for patients with heart failure.
Press release
The University of Dundee’s Professor James Chalmers is the Scottish lead of a major UK research study into the long-term health impacts of Covid-19 on hospitalised patients launched today.
Press release
When Ashley Giam left Singapore for the UK, she could not have imagined that the move would lead to her working on potential treatments for the deadliest pandemic the world has seen for a century.
Press release
A drug which reduces the risk of people living with a chronic lung disease from needing antibiotics or emergency hospital treatment could soon be a reality, according to the results of a clinical trial.
Press release
The University of Dundee is leading the clinical trial of a new anti-inflammatory drug it is hoped may reduce instances of severe lung damage and death in Covid-19 patients.